Grant Technology has been collaborating with global biotech firm BLOK BioScience to develop a suite of products that tackles the challenges presented by the COVID-19 pandemic.
This suite of products is powered by a technology platform built around the core concepts of confidentiality and self-sovereignty.
Travel Bubble
A major hurdle our home market of Hong Kong has yet to overcome is that of unlocking cross-border travel. At present, with very few exceptions, all individuals who enter Hong Kong must undergo quarantine; this not only wreaks havoc on the sectors of the economy most dependent on tourism, but also severely hinders business. One potential solution to this is the establishment of travel bubbles.
Grant Technology is working to adapt BLOK Verify and BLOK Pass—BLOK BioScience’s self-sovereign health status attestation solutions—into tools that enable the creation of travel bubbles. Working with medical centres and businesses all over the world, our aim is initially to create health bubbles within and between corporates and small businesses that use our platform. In time, reciprocal recognition of the BLOK technology platform by businesses will coalesce to form larger health bubbles covering towns, cities, and eventually countries. Our ultimate goal is for BLOK Verify and BLOK Pass to become internationally-recognised standards that make international travel possible once more.
About BLOK BioScience
BLOK BioScience is a global biotech company that provides the technology, supply chain expertise, and protocols for businesses and governments to get our economies back on track during the pandemic—all without compromising the integrity and privacy of individuals.
With offices in the UK, Hong Kong, and Brazil, the company is led by a team of world-class experts, driven by a shared vision of healthier, more prosperous societies.